Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Caribou Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- +5 vs. Q3 2021
- Shares held
- 31.1M
- +1.00M (+3.3%) vs. Q3 2021
- Total value
- $464.7M
- −$240.0M (−34.1%) vs. Q3 2021
- New holders
- 27
- 32 more added
- Sold out
- 22
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −56,418−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −41,393−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −28,800−100.0% | Sold out |
| Columbus Hill Capital Management, L.P. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −24,488−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −15,164−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,020−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −8,800−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −8,640−100.0% | Sold out |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −4,903−100.0% | Sold out |
| Herold Advisors, Inc. | 0 | $0 | 0.00% | −2,550−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −596−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |